Aethlon Medical Inc (AEMD) shareholders
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ashkan Mapar Joint filing with Alumni Capital LP (9.58%), Alumni Capital GP LLC (9.58%) | 781,110 | 9.58% | 13G (passive) | Sep 4, 2025 |
| Intracoastal Capital LLC Joint filing with Mitchell P. Kopin (7.70%), Daniel B. Asher (7.70%) | 576,603 | 7.70% | 13G (passive) | Sep 4, 2025 |
| Armistice Capital, LLC Joint filing with Steven Boyd (9.99%) | 84,496 | 9.99% | 13G (passive) | Dec 31, 2025 |
| Jane Street Group, LLC | 35,819 | 5.00% | 13G (passive) | Oct 6, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AEMD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Hrt Financial LP | 14,549 | 2.05% | $59.00K | New | 0.00% |
| Citadel Advisors LLC | 8,595 | 1.21% | $35.39K | New | 0.00% |
| Jane Street Group, LLC | 7,776 | 1.09% | $32.01K | New | 0.00% |
| Shay Capital LLC | 6,214 | 0.87% | $25.59K | +3,389 | 0.00% |
| Virtu Financial LLC | 5,563 | 0.78% | $23.00K | New | 0.00% |
| Ikarian Capital, LLC | 2,873 | 0.40% | $11.83K | – | 0.00% |
| Geode Capital Management, LLC | 2,038 | 0.29% | $8.39K | −2,835 | 0.00% |
| Scientech Research LLC | 2,011 | 0.28% | $8.28K | New | 0.01% |
| UBS Group AG | 1,775 | 0.25% | $7.31K | +1,596 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,266 | 0.18% | $5.21K | +944 | 0.00% |
| Morgan Stanley | 494 | 0.07% | $2.04K | +85 | 0.00% |
| Jones Financial Companies Lllp | 3 | 0.00% | $15 | New | 0.00% |
| Integrated Wealth Concepts LLC | 3 | 0.00% | $12 | New | 0.00% |
| Group One Trading, L.P. | 3 | 0.00% | $12 | – | 0.00% |
| BlackRock, Inc. | 2 | 0.00% | $8 | – | 0.00% |
| Wells Fargo & Company/Mn | 1 | 0.00% | $2 | – | 0.00% |
| Northwestern Mutual Wealth Management Co | 0 | 0.00% | $2 | New | 0.00% |
| Danske Bank A/S | 0 | 0.00% | $1 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 18 | 0M | 7.5% | 8 / 4 | 1 / 2 | 0M | 0M |
| Q1 2026 | 12 | 0M | 2.0% | 6 / 0 | 0 / 2 | 0M | 0M |
| Q4 2025 | 8 | 0M | 0.5% | 8 / 0 | 0 / 1 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| James B. Frakes | CFO/CEO, Director | 42,063 | 5.91% | Oct 13, 2026 |
| Steven P. Larosa | Chief Medical Officer | 42,057 | 5.91% | Oct 15, 2026 |
| Chetan Shah | Director | 3,787 | 0.53% | Oct 15, 2026 |
| Nicolas Gikakis | Director | 3,784 | 0.53% | Oct 15, 2026 |
| Edward G. Broenniman | Director | 4,313 | 0.61% | Oct 15, 2026 |
| Angela Rossetti | Director | 4,846 | 0.68% | Oct 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Steven P. Larosa Chief Medical Officer | Oct 8, 2026 | Award | +42,000 | – | – | 42,057 |
| James B. Frakes CFO/CEO, Director | Oct 8, 2026 | Award | +42,000 | – | – | 42,063 |
| Chetan Shah Director | Sep 30, 2026 | Tax withholding | −436 | $6.52 | $2.84K | 3,787 |
| Nicolas Gikakis Director | Sep 30, 2026 | Tax withholding | −436 | $6.52 | $2.84K | 3,784 |
| Edward G. Broenniman Director | Sep 30, 2026 | Tax withholding | −218 | $6.52 | $1.42K | 4,313 |
| Edward G. Broenniman Director | Jun 30, 2026 | Tax withholding | −1,091 | $0.82 | $895 | 22,363 |
| Nicolas Gikakis Director | Jun 30, 2026 | Tax withholding | −2,182 | $0.82 | $1.79K | 20,663 |
| Chetan Shah Director | Jun 30, 2026 | Tax withholding | −2,182 | $0.82 | $1.79K | 20,840 |
| Angela Rossetti Director | Apr 17, 2026 | Award | +21,815 | $2.29 | $49.96K | 4,846 |
| Edward G. Broenniman Director | Apr 17, 2026 | Award | +21,815 | $2.29 | $49.96K | 23,454 |
| Angela Rossetti Director | Apr 17, 2026 | Award | +21,815 | $2.29 | $49.96K | 26,207 |
| Chetan Shah Director | Apr 17, 2026 | Award | +21,815 | $2.29 | $49.96K | 23,021 |
| Nicolas Gikakis Director | Apr 17, 2026 | Award | +21,815 | $2.29 | $49.96K | 22,844 |
| Chetan Shah Director | Mar 31, 2026 | Tax withholding | −178 | $2.19 | $390 | 1,463 |
| Nicolas Gikakis Director | Mar 31, 2026 | Tax withholding | −178 | $2.19 | $390 | 1,464 |
| Edward G. Broenniman Director | Mar 31, 2026 | Tax withholding | −89 | $2.19 | $195 | 1,915 |
| Edward G. Broenniman Director | Dec 31, 2025 | Tax withholding | −89 | $2.77 | $247 | 2,807 |
| Nicolas Gikakis Director | Dec 31, 2025 | Tax withholding | −179 | $2.77 | $496 | 2,357 |
| Chetan Shah Director | Dec 31, 2025 | Tax withholding | −179 | $2.77 | $496 | 2,356 |
| Edward G. Broenniman Director | Sep 30, 2025 | Tax withholding | −893 | $0.75 | $670 | 25,397 |
| Chetan Shah Director | Sep 30, 2025 | Tax withholding | −1,786 | $0.75 | $1.34K | 22,672 |
| Nicolas Gikakis Director | Sep 30, 2025 | Tax withholding | −1,786 | $0.75 | $1.34K | 22,683 |
| Edward G. Broenniman Director | Jun 30, 2025 | Tax withholding | −893 | $1.20 | $1.07K | 21,825 |
| Nicolas Gikakis Director | Jun 30, 2025 | Tax withholding | −1,786 | $1.20 | $2.14K | 20,004 |
| Chetan Shah Director | Jun 30, 2025 | Tax withholding | −1,786 | $1.20 | $2.14K | 19,993 |
| Angela Rossetti Director | Apr 23, 2025 | Award | +142,857 | $0.35 | $50.00K | 343,400 |
| Nicolas Gikakis Director | Apr 23, 2025 | Award | +142,857 | $0.35 | $50.00K | 174,320 |
| Chetan Shah Director | Apr 23, 2025 | Award | −142,857 | $0.36 | $51.43K | 174,233 |
| Edward G. Broenniman Director | Apr 23, 2025 | Award | +142,857 | $0.35 | $50.00K | 181,741 |
| Edward G. Broenniman Director | Mar 31, 2025 | Tax withholding | −1,645 | $0.36 | $592 | 38,884 |
| Chetan Shah Director | Mar 31, 2025 | Tax withholding | −3,289 | $0.36 | $1.18K | 31,376 |
| Nicolas Gikakis Director | Mar 31, 2025 | Tax withholding | −3,289 | $0.36 | $1.18K | 31,463 |
| Nicolas Gikakis Director | Dec 31, 2024 | Tax withholding | −3,289 | $0.86 | $2.83K | 34,752 |
| Chetan Shah Director | Dec 31, 2024 | Tax withholding | −3,289 | $0.86 | $2.83K | 34,665 |
| Edward G. Broenniman Director | Dec 31, 2024 | Tax withholding | −1,645 | $0.86 | $1.41K | 40,529 |
| Edward G. Broenniman Director | Sep 30, 2024 | Tax withholding | −1,645 | $0.47 | $773 | 42,174 |
| Chetan Shah Director | Sep 30, 2024 | Tax withholding | −3,289 | $0.47 | $1.55K | 37,954 |
| Nicolas Gikakis Director | Sep 30, 2024 | Tax withholding | −3,289 | $0.47 | $1.55K | 38,041 |
| Edward G. Broenniman Director | Jun 28, 2024 | Tax withholding | −1,645 | $0.50 | $823 | 43,819 |
| Chetan Shah Director | Jun 28, 2024 | Tax withholding | −3,289 | $0.50 | $1.64K | 41,243 |
| Nicolas Gikakis Director | Jun 28, 2024 | Tax withholding | −5,244 | $0.50 | $2.62K | 41,330 |
| Edward G. Broenniman Director | Apr 16, 2024 | Award | +32,894 | $1.52 | $50.00K | 45,464 |
| Nicolas Gikakis Director | Apr 16, 2024 | Award | +32,894 | $1.52 | $50.00K | 46,574 |
| Angela Rossetti Director | Apr 16, 2024 | Award | +32,894 | $1.52 | $50.00K | 200,543 |
| Chetan Shah Director | Apr 16, 2024 | Award | +32,894 | $1.52 | $50.00K | 44,532 |
| Nicolas Gikakis Director | Mar 29, 2024 | Tax withholding | −1,954 | $1.68 | $3.28K | 13,680 |
| Edward G. Broenniman Director | Mar 29, 2024 | Tax withholding | −1,163 | $1.68 | $1.95K | 12,570 |
| Chetan Shah Director | Mar 29, 2024 | Tax withholding | −1,163 | $1.68 | $1.95K | 11,638 |
| Chetan Shah Director | Dec 29, 2023 | Tax withholding | −1,163 | $2.19 | $2.55K | 12,801 |
| Edward G. Broenniman Director | Dec 29, 2023 | Tax withholding | −1,163 | $2.19 | $2.55K | 13,733 |
| Nicolas Gikakis Director | Dec 29, 2023 | Tax withholding | −1,954 | $2.19 | $4.28K | 15,634 |
| Edward G. Broenniman Director | Sep 29, 2023 | Tax withholding | −11,628 | $0.23 | $2.67K | 148,957 |
| Nicolas Gikakis Director | Sep 29, 2023 | Tax withholding | −19,541 | $0.23 | $4.49K | 175,873 |
| Chetan Shah Director | Sep 29, 2023 | Tax withholding | −11,628 | $0.23 | $2.67K | 139,637 |
| Nicolas Gikakis Director | Jul 3, 2023 | Award | +195,414 | – | – | 195,414 |
| Chetan Shah Director | Jun 30, 2023 | Tax withholding | −11,628 | $0.36 | $4.19K | 151,265 |
| Edward G. Broenniman Director | Jun 30, 2023 | Tax withholding | −11,628 | $0.36 | $4.19K | 160,585 |
| Chetan Shah Director | Apr 28, 2023 | Award | +116,279 | – | – | 162,893 |
| Angela Rossetti Director | Apr 28, 2023 | Award | +116,279 | – | – | 167,649 |
| Edward G. Broenniman Director | Apr 28, 2023 | Award | +116,279 | – | – | 172,213 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Aethlon Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 246,697 shares on Sep 18, 2026 over the last 90 days.
See a number that looks wrong?